6CM
YARW

683 Capital Management’s Yarrow Bioscience YARW Stock Holding History

683 Capital Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-795
Closed -$994K – 360
2021
Q3 		$994K Sell
795
-20
-2% -$38.8K 0.04% 143
2021
Q2 		$2.58M Buy
+815
New +$3.23M 0.09% 111
2021
Q1 		– Sell
-1,658
Closed -$9.43M – 237
2020
Q4 		$9.43M Hold
1,658
– – 0.45% 49
2020
Q3 		$9.91M Buy
1,658
+116
+8% +$677K 0.73% 34
2020
Q2 		$9.6M Buy
1,542
+987
+178% +$6.68M 0.77% 30
2020
Q1 		$5.35M Buy
+555
New +$8.7M 0.63% 39

Other funds holding YARW

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

683 Capital Management's YARW Position: Q4 2021 in Review

683 Capital Management sold out of Yarrow Bioscience (YARW) in Q4 2021, closing a stake of 795 shares — an estimated $994K sold.

683 Capital Management first reported a position in YARW in Q1 2020 and held it in 6 quarters. The position peaked at $9.91M in Q3 2020. 49 funds tracked by Wall St. Rank hold YARW as of Q4 2021.

  • 683 Capital Management reported no remaining Yarrow Bioscience position as of Q4 2021 after selling out during the quarter.
  • 683 Capital Management sold 795 Yarrow Bioscience shares in Q4 2021, an estimated $994K.
  • 683 Capital Management first reported a position in Yarrow Bioscience in Q1 2020 and held it in 6 quarters.
  • 683 Capital Management's Yarrow Bioscience position peaked at $9.91M in Q3 2020.
  • 49 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q4 2021.

Based on 683 Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.